Earnings summaries and quarterly performance for Bunge Global.
Executive leadership at Bunge Global.
Board of directors at Bunge Global.
AI
Adrian Isman
Detailed
Director
AJ
Anne Jensen
Detailed
Director
CB
Carol Browner
Detailed
Director
CM
Christopher Mahoney
Detailed
Director
EA
Eliane Aleixo Lustosa de Andrade
Detailed
Director
JW
Jay Winship
Detailed
Director
KS
Kenneth Simril
Detailed
Director
LJ
Linda Jojo
Detailed
Director
MZ
Mark Zenuk
Detailed
Chair of the Board
MW
Markus Walt
Detailed
Director
MM
Monica McGurk
Detailed
Director
Research analysts who have asked questions during Bunge Global earnings calls.
HJ
Heather Jones
Heather Jones Research
8 questions for BG
Also covers: ADM, CALM, DAR +6 more
MG
Manav Gupta
UBS Group
8 questions for BG
Also covers: ADM, AMTX, BE +35 more
Salvator Tiano
Bank of America
8 questions for BG
Also covers: ADM, CE, EMN +7 more
SH
Steven Haynes
Morgan Stanley
8 questions for BG
Also covers: ADM, APD, ASH +3 more
Andrew Strelzik
BMO Capital Markets
7 questions for BG
Also covers: ADM, BLMN, DAR +17 more
DW
Derrick Whitfield
Texas Capital
7 questions for BG
Also covers: AMTX, ARIS, CHRD +21 more
PS
Pooran Sharma
Stephens Inc.
5 questions for BG
Also covers: ADM, ANDE, AVO +12 more
TP
Thomas Palmer
Citigroup Inc.
5 questions for BG
Also covers: ADM, BRBR, CAG +14 more
BT
Benjamin Theurer
Barclays Corporate & Investment Bank
3 questions for BG
Also covers: ADM, BYND, CF +15 more
BT
Ben Theurer
Barclays
2 questions for BG
Also covers: ADM, CX, HRL +7 more
BT
Ben Toyrer
Barclays
2 questions for BG
Matthew Blair
Tudor, Pickering, Holt & Co.
2 questions for BG
Also covers: AMTX, CE, CLNE +20 more
Puran Sharma
Stevens Inc.
2 questions for BG
Also covers: TSN
TP
Tom Palmer
JPMorgan Chase & Co.
2 questions for BG
Also covers: ACI, ADM, CAG +11 more
AS
Andrew Stravik
BMO Capital Markets
1 question for BG
RP
Rahi Parikh
Barclays
1 question for BG
Also covers: HRL, ICL, KOF +1 more
TZ
Tami Zakaria
JPMorgan Chase & Co.
1 question for BG
Also covers: ADM, AGCO, ALSN +23 more
Recent press releases and 8-K filings for BG.
Bunge reports Q4 2025 results and 2026 outlook
BG
Earnings
Guidance Update
M&A
- Completed Viterra combination, realizing > $70 million in run‐rate synergies by end-2025 and targeting $190 million of synergies in 2026 (run rate $220 million by year-end).
- Q4 2025: reported EPS $0.49 vs. $4.36 LY; adjusted EPS $1.99 vs. $2.13 LY; adjusted EBIT $756 million vs. $546 million LY; results included mark-to-market timing and integration costs.
- 2026 guidance: adjusted EPS $7.50–$8.00, annual tax rate 23–27%, net interest expense $575–$625 million, CapEx $1.5–$1.7 billion, D&A ~$975 million.
- FY 2025 cash flow and leverage: adjusted FFO $1.7 billion, discretionary cash flow $1.25 billion, year-end net debt $700 million (ex-RMI), and adjusted leverage 1.9×.
3 days ago
Bunge reports Q4 2025 results
BG
Earnings
Guidance Update
- Q4 adjusted EPS was $1.99 (vs. $2.13 in Q4 2024) and Q4 adjusted Total EBIT reached $622 M (vs. $445 M).
- FY 2025 adjusted EPS declined to $7.57 (from $9.19 in FY 2024) while FY 2025 adjusted Total EBIT was $2.034 B (vs. $2.017 B).
- The company generated FY 2025 discretionary cash flow of $1.248 B, allocating $459 M to dividends, $1.173 B to growth capex and $551 M to share buybacks.
- For FY 2026, Bunge guides adjusted EPS of $7.50–$8.00, with net interest expense of $575 M–$625 M and capex of $1.5 B–$1.7 B.
3 days ago
Bunge Global reports Q4 2025 results
BG
Earnings
Guidance Update
M&A
- Q4 reported EPS of $0.49 was weighed down by a $0.55 mark-to-market timing charge and $0.95 of notable items; adjusted EPS was $1.99 vs $2.13 in Q4 2024, and adjusted EBIT rose to $756 million from $546 million year-over-year.
- Integration of Viterra completed in 2025, with $70 million of synergies realized; management now targets $190 million of synergy capture in 2026 and a year-end run rate of $220 million.
- For 2026, Bunge forecasts adjusted EPS of $7.50–$8.00, an effective tax rate of 23–27%, net interest expense of $575–$625 million, capital expenditures of $1.5–$1.7 billion, and depreciation & amortization of ~$975 million.
- At year-end, net debt (ex-RMI) stood at $700 million with an adjusted leverage ratio of 1.9×, and liquidity remained strong with $9 billion of undrawn committed credit facilities.
3 days ago
Bunge reports Q4 2025 earnings results
BG
Earnings
Guidance Update
M&A
- Completed the Viterra integration and expects $190 million of realized synergies in 2026, with a $220 million run rate by year-end
- Q4 2025 reported EPS of $0.49 (Q4 2024: $4.36) and adjusted EPS of $1.99, with adjusted EBIT of $756 million
- Issued 2026 guidance of $7.50–$8.00 adjusted EPS; effective tax rate 23%–27%; net interest expense $575–$625 million; CapEx $1.5–$1.7 billion; depreciation & amortization ~$975 million
- 2025 capital allocation: generated $1.7 billion of adjusted funds from operations, paid $459 million in dividends, and repurchased 6.7 million shares for $551 million
3 days ago
Bunge reports Q4 and full-year 2025 results
BG
Earnings
Guidance Update
- Full-year GAAP diluted EPS of $4.93 vs. $7.99 in 2024; adjusted EPS of $7.57 vs. $9.19
- Q4 GAAP diluted EPS of $0.49 vs. $4.36 in Q4 2024; adjusted EPS of $1.99 vs. $2.13
- Adjusted total EBIT of $622 million in Q4 and $2,034 million for the full year
- 2026 guidance: adjusted EPS of $7.50–$8.00; adjusted tax rate 23–27%; net interest expense $575–$625 million; capex $1.5–$1.7 billion
3 days ago
Bunge Global reports Q4 and full-year 2025 results
BG
Earnings
Guidance Update
M&A
- Completed combination with Viterra, advancing growth projects and capturing operational synergies.
- Reported full-year GAAP diluted EPS of $4.93 vs $7.99 prior year and adjusted EPS of $7.57 vs $9.19.
- Delivered Q4 GAAP diluted EPS of $0.49 vs $4.36 prior year and adjusted EPS of $1.99 vs $2.13.
- Issued 2026 guidance for adjusted EPS of $7.50–$8.00, tax rate 23–27%, net interest expense $575–$625 million, and CapEx $1.5–$1.7 billion.
3 days ago
Bunge Global reports Q3 2025 results
BG
Earnings
Guidance Update
Share Buyback
- Third-quarter net sales rose 72% to $22.15 billion on volume growth and the Viterra acquisition.
- Net income declined to $166 million from $221 million a year earlier.
- Adjusted EPS of $2.27 topped analyst estimates.
- Company maintained full-year adjusted EPS guidance of $7.30–$7.60.
- Announced a $545 million share repurchase program to support shareholder value.
Nov 5, 2025, 7:59 PM
Bunge reports Q3 2025 results
BG
Earnings
Guidance Update
M&A
- Delivered adjusted EPS of $2.27 and adjusted EBIT of $924 million in Q3 2025, despite reported EPS of $0.86 including mark-to-market and transaction charges.
- First quarter operating as a combined Bunge-Viterra entity, with reportable segments realigned into soybean processing, softseed processing, other oilseeds processing, and grain merchandising and milling to enhance end-to-end value-chain integration.
- Reaffirmed full-year 2025 adjusted EPS guidance of $7.30–$7.60 (second-half EPS of $4.00–$4.25), with net interest expense expected at $380–$400 million and capital expenditures of $1.6–$1.7 billion.
- Year-to-date generated $1.2 billion of adjusted funds from operations and $900 million of discretionary cash flow; deployed $324 million to dividends, $903 million to growth CapEx, and repurchased 6.7 million shares for $545 million.
- At quarter-end, net debt exceeded readily marketable inventories by ~$900 million, adjusted leverage was 2.2×, and $9.7 billion of committed credit facilities remained unused.
Nov 5, 2025, 1:00 PM
Bunge Global SA reports Q3 2025 results
BG
Earnings
Guidance Update
- Adjusted EPS of $2.27 in Q3 2025 was essentially flat year-over-year, while net income per diluted share from continuing operations declined to $0.86 from $1.56 a year ago.
- Adjusted Segment EBIT rose to $924 million (Q3 2024: $559 million) and Adjusted Total EBIT increased to $757 million (Q3 2024: $491 million), driven by integration benefits.
- Maintained full-year 2025 guidance for adjusted EPS of $7.30–$7.60, including H2 EPS of $4.00–$4.25, with a 23–25% tax rate, $380–$400 million net interest expense, $1.6–$1.7 billion capex and ~$710 million D&A.
- Management noted favorable industry trends but highlighted ongoing uncertainty from macroeconomic, trade and biofuel policy dynamics.
Nov 5, 2025, 1:00 PM
Bunge reports Q3 2025 earnings and reiterates full-year guidance
BG
Earnings
Guidance Update
M&A
- Reported Q3 EPS of $0.86 and adjusted EPS of $2.27, with adjusted segment EBIT rising to $924 million from $559 million year-over-year.
- Completed first quarter operating as a combined company with Viterra, realizing early integration benefits across origination and processing and capturing initial commercial synergies.
- Maintains full-year 2025 adjusted EPS guidance of $7.30–$7.60, with H2 adjusted EPS expected at $4.00–$4.25; 2025 capex is pegged at $1.6–$1.7 billion and net interest expense at $380–$400 million.
- Generated approximately $1.2 billion of YTD adjusted funds from operations and repurchased 6.7 million shares for $545 million, with $255 million remaining under the Viterra buyback program.
Nov 5, 2025, 1:00 PM
Quarterly earnings call transcripts for Bunge Global.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more